Monoclonal antibody mechanisms of action in cancer

Area of Science:

• Immunology
• Oncology
• Pharmacology

Background:

• Monoclonal antibodies (mAbs) are a cornerstone in modern cancer therapy.
• Their efficacy relies on diverse biological mechanisms to eliminate tumor cells.

Purpose of the Study:

• To review the multifaceted mechanisms of anti-tumor action for monoclonal antibodies (mAbs).
• To summarize in vitro, animal model, and clinical evidence supporting these mechanisms.
• To explore potential interactions between different mAb-mediated anti-tumor effects.

Main Methods:

• Literature review of in vitro studies.
• Analysis of preclinical animal model data.
• Examination of clinical trial results.

Main Results:

• mAbs exert anti-tumor effects via antigen cross-linking, growth signal blockade, antibody-dependent cellular cytotoxicity (ADCC), and complement-mediated cytotoxicity (CMC).
• mAbs can also modulate the cytokine environment and enhance anti-tumor immune responses.
• Evidence supports the individual and potentially synergistic roles of these mechanisms.

Conclusions:

• Monoclonal antibodies employ a range of mechanisms to achieve anti-cancer effects.
• Understanding these mechanisms, including ADCC and CMC, is crucial for optimizing cancer immunotherapy.
• Further research into the interplay of these mechanisms may reveal novel therapeutic strategies.